| Insideraktier | 26.630.802 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Radius Recycling, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RDUS / Radius Recycling, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RDUS / Radius Recycling, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 | 2022-08-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 10,0000 | -8.733.538 | -87.335 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 10,0000 | -5.500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Murphy Sean | RDUS | Common Stock | D | 10,0000 | -5.500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10,0000 | -5.500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10,0000 | -26.800 | -268 | 5.500 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 10,0000 | -75.000 | -750 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 10,0000 | -25.000 | -250 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Messersmith Elizabeth | RDUS | Common Stock | D | 10,0000 | -70.000 | -700 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Hughes Owen | RDUS | Common Stock | D | 10,0000 | -21.650 | -216 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10,0000 | -1.895 | -19 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10,0000 | -21.300 | -213 | 1.895 | ||||
| 2022-08-15 | 2022-08-15 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 10,0000 | -26.800 | -268 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10,0000 | -94.645 | -946 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 10,0000 | -5.500 | -55 | 0 | ||||
| 2022-08-12 | 2022-08-11 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10,0700 | 1.678.954 | 16.907 | 8.642.271 | ||||
| 2022-08-11 | 2022-08-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10,0700 | 4.012 | 40 | 6.963.317 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Lisa Susan Vissers | RDUS | Stock Option (Right to Buy) | D | 5,84 | 30.000 | 30.000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | Jarrett Jennifer | RDUS | Stock Option (Right to Buy) | D | 5,84 | 30.000 | 30.000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 5,5690 | 477.824 | 2.661 | 8.733.538 | ||||
| 2022-03-17 | 2022-03-15 | 4 | Conley Mark William | RDUS | Common Stock | D | 50.000 | 50.000 | ||||||
| 2022-02-28 | 3 | Messersmith Elizabeth | RDUS | Common Stock | D | 70.000 | ||||||||
| 2022-02-25 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 75.000 | 75.000 | ||||||
| 2022-02-23 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 960.000 | 960.000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Helwig Steven | RDUS | Common Stock | D | 15.000 | 31.251 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 5.500 | 5.500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Common Stock | D | 5.500 | 21.650 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 5.500 | 5.500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Shah Chhaya | RDUS | Common Stock | D | 65.000 | 94.645 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5.500 | 26.800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Common Stock | D | 5.500 | 23.195 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5.500 | 26.800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 25.000 | 25.000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 6,40 | 10.000 | 10.000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Common Stock | D | 5.500 | 11.000 | ||||||
| 2022-01-07 | 2022-01-06 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6,3147 | 300.000 | 1.894 | 8.255.714 | ||||
| 2022-01-07 | 2022-01-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6,2986 | 250.000 | 1.575 | 7.955.714 | ||||
| 2021-12-16 | 2021-12-16 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7,0747 | 146.685 | 1.038 | 6.959.305 | ||||
| 2021-12-15 | 2021-12-15 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6,7700 | 180.744 | 1.224 | 6.812.620 | ||||
| 2021-12-15 | 2021-12-14 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6,8110 | 94.103 | 641 | 6.631.876 | ||||
| 2021-12-15 | 2021-12-13 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7,0804 | 187.391 | 1.327 | 6.537.773 | ||||
| 2021-12-10 | 2021-12-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7,1750 | 768.171 | 5.512 | 6.350.382 | ||||
| 2021-12-10 | 2021-12-09 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7,5841 | 264.644 | 2.007 | 5.582.211 | ||||
| 2021-12-10 | 2021-12-08 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 8,0206 | 560.691 | 4.497 | 5.317.567 | ||||
| 2021-12-10 | 3 | Rubric Capital Management LP | RDUS | Common stock, par value $0.0001 per share | I | 4.756.876 | ||||||||
| 2021-10-18 | 2021-10-15 | 4 | Holtschlag Danielle | RDUS | Stock Option (Right to Buy) | D | 15,10 | 50.000 | 50.000 | |||||
| 2021-10-01 | 2021-09-29 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12,9450 | 100.000 | 1.294 | 7.705.714 | ||||
| 2021-09-24 | 2021-09-22 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12,2752 | 150.000 | 1.841 | 7.605.714 | ||||
| 2021-09-23 | 2021-05-17 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10.000 | 29.645 | ||||||
| 2021-08-26 | 2021-08-24 | 4 | Helwig Steven | RDUS | Common | D | 5.125 | 20.829 | ||||||
| 2021-08-26 | 3 | Helwig Steven | RDUS | Common Stock | D | 15.704 | ||||||||
| 2021-03-24 | 3 | Shah Chhaya | RDUS | Common Stock | D | 19.645 | ||||||||
| 2021-03-24 | 2021-02-22 | 4/A | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28,60 | 460.000 | 460.000 | |||||
| 2021-03-09 | 2021-03-05 | 4 | Chopas James George | RDUS | Common Stock | D | 20,8800 | -370 | -8 | 6.701 | ||||
| 2021-02-26 | 2021-02-25 | 4 | Grausso Sal | RDUS | Common Stock | D | 18,9300 | -1.322 | -25 | 11.709 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 18,60 | 20.000 | 20.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 18,60 | 60.000 | 60.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10.000 | 10.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Common Stock | D | 5.500 | 5.500 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10.000 | 10.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5.500 | 17.695 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10.000 | 10.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5.500 | 21.300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10.000 | 10.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5.500 | 21.300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28,60 | 460.000 | 460.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 18,60 | 10.000 | 10.000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5.500 | 16.150 | ||||||
| 2021-01-25 | 2021-01-21 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20.000 | 20.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20.000 | 20.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20.000 | 20.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 22,00 | 20.000 | 20.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 22,00 | 40.000 | 40.000 | |||||
| 2021-01-21 | 2021-01-20 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 21,66 | 20.000 | 20.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 18,17 | 30.000 | 30.000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 18,17 | 30.000 | 30.000 | |||||
| 2020-12-18 | 3 | Chopas James George | RDUS | Common Stock | D | 1.492 | ||||||||
| 2020-11-10 | 2020-11-09 | 4 | Dolan Dan | RDUS | Stock Option (Right to Buy) | D | 14,08 | 12.000 | 12.000 | |||||
| 2020-11-10 | 2020-11-09 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 14,08 | 15.000 | 15.000 | |||||
| 2020-11-10 | 3 | Grausso Sal | RDUS | Common Stock | D | 531 | ||||||||
| 2020-11-09 | 2020-11-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 14,2623 | 100.000 | 1.426 | 7.455.714 | ||||
| 2020-09-16 | 2020-09-14 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11,6934 | 200.000 | 2.339 | 7.355.714 | ||||
| 2020-09-14 | 2020-09-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11,3306 | 199.029 | 2.255 | 7.155.714 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 12,61 | 30.000 | 30.000 | |||||
| 2020-07-09 | 2020-07-08 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 13,2071 | 25.000 | 330 | 6.956.685 | ||||
| 2020-05-04 | 2020-04-30 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 15,7511 | 50.000 | 788 | 6.931.685 | ||||
| 2020-04-29 | 2020-04-28 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 16,46 | 575.000 | 575.000 | |||||
| 2020-02-28 | 2020-02-26 | 4 | Carmona Jose | RDUS | Common Stock | D | 17,9330 | -1.292 | -23 | 46.708 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Dere Willard H | RDUS | Common Stock | D | 17,9500 | -1.925 | -35 | 12.195 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 17,9500 | -1.815 | -33 | 12.401 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Morris Charles Q | RDUS | Common Stock | D | 17,9330 | -1.256 | -23 | 33.744 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Hughes Owen | RDUS | Common Stock | D | 17,9500 | -2.750 | -49 | 10.650 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17,9330 | -889 | -16 | 24.111 | ||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5.500 | 15.800 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Common Stock | D | 5.500 | 11.000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19,96 | 107.000 | 107.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 5.500 | 18.300 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Common Stock | D | 5.500 | 13.400 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19,96 | 25.000 | 25.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17.500 | 25.000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,96 | 30.000 | 30.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Common Stock | D | 20.000 | 35.000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5.500 | 14.216 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19,96 | 45.000 | 45.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Common Stock | D | 30.000 | 48.000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock | D | 5.500 | 14.120 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 19,96 | 10.000 | 10.000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5.500 | 15.800 | ||||||
| 2019-11-08 | 2019-11-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 23,0030 | 100.000 | 2.300 | 6.881.685 | ||||
| 2019-07-03 | 2019-07-01 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 24,6000 | -1.584 | -39 | 8.716 | ||||
| 2019-06-11 | 2019-06-07 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21,8144 | 2.500 | 55 | 7.500 | ||||
| 2019-05-13 | 2019-05-10 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21,4300 | 2.000 | 43 | 5.000 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Dere Willard H | RDUS | Common Stock | D | 22,2200 | -1.680 | -37 | 8.620 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Graves Kurt | RDUS | Common Stock | D | 22,3200 | -4.800 | -107 | 5.500 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Hughes Owen | RDUS | Common Stock | D | 22,2200 | -2.400 | -53 | 7.900 | ||||
| 2019-04-12 | 2019-04-11 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 22,1500 | -4.800 | -106 | 5.500 | ||||
| 2019-03-06 | 2019-03-05 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 19,2336 | 12.800 | 246 | 12.800 | ||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55.000 | 55.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Common Stock | D | 15.000 | 18.000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55.000 | 55.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Common Stock | D | 15.000 | 15.000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19,18 | 30.000 | 30.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 10.000 | 13.000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Performance Stock Units | D | 71.000 | 71.000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19,18 | 128.000 | 128.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 19,18 | 55.000 | 55.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 15.000 | 17.944 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Options (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19,18 | 10.000 | 10.000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5.500 | 10.300 | ||||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14,00 | -71.409 | 0 | |||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,0040 | 71.409 | 1.000 | 6.781.685 | ||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | -4.800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 4.800 | 4.800 | ||||||
| 2019-01-25 | 2019-01-24 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 17,10 | 30.000 | 30.000 | |||||
| 2018-12-21 | 2018-12-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,4797 | 60.000 | 869 | 6.710.276 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 15,7100 | 3.000 | 47 | 3.000 | ||||
| 2018-12-17 | 2018-12-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 15,6376 | 60.000 | 938 | 6.650.276 | ||||
| 2018-09-05 | 2018-09-04 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19,93 | 130.000 | 130.000 | |||||
| 2018-08-22 | 2018-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 19,6468 | 60.000 | 1.179 | 6.590.276 | ||||
| 2018-08-16 | 2018-08-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20,7824 | 69.363 | 1.442 | 6.530.276 | ||||
| 2018-08-16 | 2018-08-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20,8688 | 100.000 | 2.087 | 6.460.913 | ||||
| 2018-08-10 | 2018-08-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 22,7314 | 60.000 | 1.364 | 6.360.913 | ||||
| 2018-07-30 | 2018-07-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 24,8121 | 50.000 | 1.241 | 6.300.913 | ||||
| 2018-07-26 | 2018-07-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27,2761 | 50.000 | 1.364 | 6.250.913 | ||||
| 2018-06-13 | 2018-06-11 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27,3567 | 50.000 | 1.368 | 6.200.913 | ||||
| 2018-05-24 | 2018-05-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 28,9080 | 40.000 | 1.156 | 6.150.913 | ||||
| 2018-05-23 | 2018-05-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29,2730 | 60.000 | 1.756 | 6.110.913 | ||||
| 2018-04-23 | 2018-04-19 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,7984 | 40.000 | 1.352 | 6.050.913 | ||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14,00 | -107.114 | 71.409 | |||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14,0040 | 107.114 | 1.500 | 6.010.913 | ||||
| 2018-04-09 | 2018-04-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,5769 | 50.000 | 1.829 | 5.903.799 | ||||
| 2018-03-06 | 2018-03-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,5181 | 80.000 | 2.601 | 5.853.799 | ||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60.000 | 60.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60.000 | 60.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60.000 | 60.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 37,83 | 210.000 | 210.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 37,83 | 30.000 | 30.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | 4.800 | 4.800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37,83 | 8.800 | 8.800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 37,83 | 60.000 | 60.000 | |||||
| 2018-02-12 | 2018-02-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,3835 | 75.000 | 2.579 | 5.773.799 | ||||
| 2017-11-28 | 2017-11-27 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 27,80 | 60.000 | 60.000 | |||||
| 2017-11-16 | 2017-11-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 26,2478 | 50.000 | 1.312 | 5.698.799 | ||||
| 2017-11-13 | 2017-11-10 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 28,0893 | 1.778 | 50 | 2.278 | ||||
| 2017-11-07 | 2017-11-07 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 29,0368 | 6.800 | 197 | 12.900 | ||||
| 2017-11-07 | 2017-11-03 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29,1515 | 50.000 | 1.458 | 5.648.799 | ||||
| 2017-10-27 | 2017-10-26 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 30,9510 | 50.000 | 1.548 | 5.598.799 | ||||
| 2017-10-26 | 2017-10-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,8483 | 50.000 | 1.642 | 5.548.799 | ||||
| 2017-09-15 | 2017-09-15 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 32,7227 | 6.100 | 200 | 6.100 | ||||
| 2017-09-15 | 2017-09-14 | 4 | Carmona Jose | RDUS | Common Stock | D | 32,8343 | 3.000 | 99 | 3.000 | ||||
| 2017-09-15 | 2017-09-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,9445 | 50.000 | 1.647 | 5.498.799 | ||||
| 2017-09-15 | 2017-09-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,7075 | 100.000 | 3.371 | 5.448.799 | ||||
| 2017-09-13 | 2017-09-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,4164 | 50.000 | 1.771 | 5.348.799 | ||||
| 2017-09-07 | 2017-09-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,7525 | 50.000 | 1.838 | 5.298.799 | ||||
| 2017-08-18 | 2017-08-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,9756 | 60.000 | 2.159 | 5.248.799 | ||||
| 2017-08-11 | 2017-08-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,2600 | 75.000 | 2.570 | 5.188.799 | ||||
| 2017-08-11 | 2017-08-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,6737 | 75.000 | 2.676 | 5.113.799 | ||||
| 2017-07-18 | 3 | Hoiland Jesper | RDUS | No securities are beneficially owned. | D | 0 | ||||||||
| 2017-07-18 | 2017-07-17 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 42,97 | 305.000 | 305.000 | |||||
| 2017-05-31 | 2017-05-30 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,2087 | 40.000 | 1.368 | 5.038.799 | ||||
| 2017-05-30 | 2017-05-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,2505 | 40.000 | 1.450 | 4.998.799 | ||||
| 2017-05-22 | 2017-05-18 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34,4069 | 50.000 | 1.720 | 4.958.799 | ||||
| 2017-05-18 | 2017-05-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32,9812 | 18.000 | 594 | 4.908.799 | ||||
| 2017-05-18 | 2017-05-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9250 | 17.000 | 577 | 4.890.799 | ||||
| 2017-05-16 | 2017-05-15 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 34,96 | 125.000 | 125.000 | |||||
| 2017-05-16 | 2017-05-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9997 | 15.000 | 510 | 4.873.799 | ||||
| 2017-05-11 | 2017-05-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,9296 | 50.000 | 1.796 | 4.858.799 | ||||
| 2017-05-09 | 2017-05-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,5978 | 22.800 | 812 | 4.808.799 | ||||
| 2017-05-09 | 2017-05-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,5477 | 20.600 | 732 | 4.785.999 | ||||
| 2017-05-03 | 2017-05-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33,9056 | 75.000 | 2.543 | 4.765.399 | ||||
| 2017-05-02 | 2017-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,3907 | 150.000 | 5.309 | 4.690.399 | ||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2,74 | -11.838 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2,74 | -27.778 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2,7400 | 39.616 | 109 | 76.189 | ||||
| 2017-03-22 | 2017-03-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35,8325 | 50.000 | 1.792 | 4.540.399 | ||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 2,05 | -23.416 | 0 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2,0500 | 23.416 | 48 | 36.573 | ||||
| 2017-03-21 | 2017-03-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38,4083 | 30.000 | 1.152 | 4.490.399 | ||||
| 2017-03-16 | 2017-03-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,9560 | 44.469 | 1.777 | 4.460.399 | ||||
| 2017-03-16 | 2017-03-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,9993 | 17.252 | 690 | 4.415.930 | ||||
| 2017-03-14 | 2017-03-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,1673 | 38.279 | 1.499 | 4.398.678 | ||||
| 2017-02-22 | 2017-02-17 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75.000 | 75.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 45,65 | 187.800 | 187.800 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75.000 | 75.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 45,65 | 45.000 | 45.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 45,65 | 55.000 | 55.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 45,65 | 75.000 | 75.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 45,65 | 60.000 | 60.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 45,65 | 35.000 | 35.000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 45,65 | 27.500 | 27.500 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | -10.000 | 733.785 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 10.000 | 78 | 15.000 | ||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | -1.229.902 | 2.459.804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | -1.229.902 | 2.459.804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GADICKE ANSBERT | RDUS | Common Stock | I | -1.943.751 | 3.887.502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | EVNIN LUKE | RDUS | Common Stock | I | -1.943.751 | 3.887.502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | -713.849 | 1.427.698 | ||||||
| 2016-06-02 | 2016-05-24 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37,07 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 29,89 | 62.500 | 62.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75.000 | 75.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 29,89 | 156.250 | 156.250 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75.000 | 75.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75.000 | 75.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 29,89 | 62.500 | 62.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 29,89 | 27.500 | 27.500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75.000 | 75.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 29,89 | 75.000 | 75.000 | |||||
| 2016-01-26 | 2016-01-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 37,9700 | 100 | 4 | 200 | ||||
| 2016-01-26 | 2015-11-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 60,5950 | 100 | 6 | 100 | ||||
| 2016-01-25 | 2016-01-22 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 31,6658 | 38.259 | 1.212 | 4.360.399 | ||||
| 2016-01-14 | 2016-01-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39,8977 | 50.000 | 1.995 | 4.322.140 | ||||
| 2015-12-07 | 2015-12-01 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 56,80 | 30.000 | 30.000 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | -25.000 | 743.785 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 62,7650 | -25.000 | -1.569 | 0 | ||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 25.000 | 195 | 25.000 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | -1 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | -5.682 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 75,0000 | -5.683 | -426 | 0 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,7400 | 5.683 | 16 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,74 | -13.333 | 0 | |||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 70,0000 | -13.333 | -933 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,7400 | 13.333 | 37 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2,05 | -10.428 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3,42 | -874 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65,0000 | -11.302 | -735 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2,0500 | 10.428 | 21 | 10.428 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3,4200 | 874 | 3 | 874 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3,42 | -1.501 | 874 | |||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65,3600 | -1.501 | -98 | 0 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3,4200 | 1.501 | 5 | 1.501 | ||||
| 2015-09-28 | 2015-09-14 | 4 | Snow David P. | RDUS | Common Stock | D | 69,7900 | 6.000 | 419 | 6.000 | ||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 65,23 | 100.000 | 100.000 | |||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Performance Units | D | 25.000 | 25.000 | ||||||
| 2015-09-08 | 2015-08-31 | 4 | Purandare Dinesh | RDUS | Common Stock | D | 62,2000 | 200 | 12 | 200 | ||||
| 2015-08-24 | 2015-08-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 63,4454 | 50.000 | 3.172 | 4.272.140 | ||||
| 2015-08-24 | 2015-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 64,5552 | 50.000 | 3.228 | 4.222.140 | ||||
| 2015-08-19 | 2015-08-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 72,51 | 30.000 | 30.000 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | -22.694 | 2.723 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 70,0000 | -22.694 | -1.589 | 0 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 22.694 | 167 | 22.694 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | -2.306 | 25.417 | |||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 70,0000 | -2.306 | -161 | 0 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 2.306 | 17 | 2.306 | ||||
| 2015-07-29 | 2015-07-27 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 73,76 | 150.000 | 150.000 | |||||
| 2015-07-27 | 2015-07-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 74,0000 | 250.000 | 18.500 | 4.172.140 | ||||
| 2015-07-20 | 2015-07-16 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 77,64 | 30.000 | 30.000 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | 25.000 | 27.723 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 69,4763 | -25.000 | -1.737 | 0 | ||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 25.000 | 184 | 25.000 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7,34 | 25.000 | 52.723 | |||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 55,0500 | -25.000 | -1.376 | 0 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 7,3400 | 25.000 | 184 | 25.000 | ||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7,80 | -5.000 | 788.974 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Common Stock | D | 7,8000 | 5.000 | 39 | 5.000 | ||||
| 2015-05-26 | 2015-05-07 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 36,74 | 15.000 | 15.000 | |||||
| 2015-05-04 | 2015-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,4593 | 50.000 | 1.823 | 3.922.140 | ||||
| 2015-04-30 | 3/A | Hatzis-Schoch Brent | RDUS | Common Stock | D | 500 | ||||||||
| 2015-04-30 | 2015-04-29 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,2316 | 50.000 | 1.812 | 3.872.140 | ||||
| 2015-04-29 | 2015-04-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38,3802 | 50.000 | 1.919 | 3.772.140 | ||||
| 2015-04-29 | 2015-04-28 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36,5855 | 50.000 | 1.829 | 3.822.140 | ||||
| 2015-03-19 | 2015-03-18 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 47,86 | 115.000 | 115.000 | |||||
| 2015-03-09 | 2015-03-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 47,0817 | 75.000 | 3.531 | 3.722.140 | ||||
| 2015-03-03 | 2015-03-02 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 44,18 | 60.000 | 60.000 | |||||
| 2015-02-27 | 2015-02-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 45,7386 | 35.000 | 1.601 | 3.647.140 | ||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7.224.280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7.224.280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7.224.280 | ||||||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14,00 | -267.786 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 14,00 | -121.396 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 14,00 | -249.932 | 0 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 14,00 | -89.261 | 267.786 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14,00 | -89.261 | 267.786 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 2,69 | -121.396 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 2,69 | -249.932 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -871.851 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | -1.794.983 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2,69 | -267.786 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | -1.167.997 | 0 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -335.820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -251.680 | 335.820 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -335.820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -251.680 | 335.820 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2,69 | -89.261 | 267.786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | -389.331 | 1.167.997 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 2,69 | -89.261 | 267.786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -389.331 | 1.167.997 | ||||||
| 2014-12-19 | 2014-12-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 30,97 | 80.000 | 80.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 30,97 | 100.000 | 100.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Stoner Elizabeth | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 30,97 | 50.000 | 50.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 30,97 | -50.000 | 50.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 30,97 | 215.000 | 215.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Jovan-Embiricos Morana | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 30,97 | 30.000 | 30.000 | |||||
| 2014-11-07 | 2014-11-01 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18,41 | 30.000 | 30.000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HARRIS ALAN G | RDUS | Employee Stock Option (Right to Buy) | D | 8,78 | 50.000 | 50.000 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -12.211 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 96.160 | 1.393.443 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -110.713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -227.938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 8,0000 | 587.500 | 4.700 | 587.500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 871.851 | 871.851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1.794.983 | 1.794.983 | ||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1.175.000 | ||||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | I | -110.713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | D | -227.938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 8,0000 | 587.500 | 4.700 | 587.500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 871.851 | 871.851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | 1.794.983 | 1.794.983 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B-2 Convertible Preferred Stock | D | -65.125 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B Convertible Preferred Stock | D | -97.688 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series A-1 Convertible Preferred Stock | D | -122.820 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 8,0000 | 1.000.000 | 8.000 | 2.705.040 | ||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 187.262 | 1.705.040 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 500.029 | 1.517.778 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 428.459 | 1.017.749 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 589.290 | 589.290 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -105.162 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -84.536 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series B Convertible Preferred Stock | I | -32.563 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 1.297.283 | 1.297.283 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -184.242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -114.537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -71.638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -859 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -3.511 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -4.346 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -1.468 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -1.340 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -5.477 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -6.779 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -2.291 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -3.752 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -15.327 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -18.975 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -6.414 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -44.395 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -181.364 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -224.528 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -75.899 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -2.985 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -12.194 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -15.096 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -5.103 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 2.141.547 | 2.141.547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 59.445 | 59.445 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 92.734 | 92.734 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 259.567 | 259.567 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 3.071.454 | 3.071.454 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 206.506 | 206.506 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | -162.813 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-3 Convertible Preferred Stock | I | -53.331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-2 Convertible Preferred Stock | I | -402.115 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-1 Convertible Preferred Stock | I | -384.261 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1.088.251 | 5.831.253 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 714.095 | 4.743.002 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 255.881 | 4.028.907 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1.929.344 | 3.773.026 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1.843.682 | 1.843.682 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred | I | -91.175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-3 Convertible Preferred Stock | I | -53.331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-2 Convertible Preferred Stock | I | -217.873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-1 Convertible Preferred Stock | I | -269.724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 694.449 | 3.689.706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 399.891 | 2.995.257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 255.881 | 2.595.366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1.045.351 | 2.339.485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1.294.134 | 1.294.134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred | I | -91.175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-3 Convertible Preferred Stock | I | -53.331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-2 Convertible Preferred Stock | I | -217.873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-1 Convertible Preferred Stock | I | -269.724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 694.449 | 3.689.706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 399.891 | 2.995.257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 255.881 | 2.595.366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1.045.351 | 2.339.485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1.294.134 | 1.294.134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | -71.638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-2 Convertible Preferred Stock | I | -184.242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-1 Convertible Preferred Stock | I | -114.537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 393.802 | 2.141.547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 314.204 | 1.747.745 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 883.993 | 1.433.541 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 549.548 | 549.548 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B Convertible Preferred Stock | I | -325.627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1.557.328 | 1.557.328 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Series B Convertible Preferred Stock | D | -325.627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | 1.557.328 | 1.557.328 | ||||||
| 2014-06-09 | 2014-06-05 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 8,00 | 65.789 | 65.789 | |||||
| 2014-06-09 | 2014-06-05 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 8,00 | 131.578 | 131.578 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Durand Mark | RDUS | Stock Option (Right to Buy) | D | 8,00 | 175.438 | 175.438 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock | I | 8,0000 | 500.000 | 4.000 | 1.943.241 | ||||
| 2014-06-09 | 2014-06-05 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 8,00 | 120.614 | 120.614 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 8,00 | 32.894 | 32.894 | |||||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6,14 | 6,1420 | 67.160 | 412 | 67.160 | |||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 26.684 | 1.639 | 26.684 | ||||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6,14 | 6,1420 | 203.518 | 1.250 | 203.518 | |||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 81.407 | 5.000 | 81.407 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6,14 | 276.783 | 276.783 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6,14 | 569.845 | 569.845 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 110.713 | 6.800 | 110.713 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 227.938 | 14.000 | 227.938 | ||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6,14 | 162.813 | 162.813 | |||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Series B-2 Convertible Preferred Stock | D | 61,4200 | 65.125 | 4.000 | 65.125 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6,14 | 30.528 | 111.936 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 12.211 | 750 | 12.211 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Yates John | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 300.000 | 1.026 | 300.000 | |||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6,14 | 276.783 | 276.783 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6,14 | 569.845 | 569.845 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 110.713 | 6.800 | 110.713 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61,4200 | 227.938 | 14.000 | 227.938 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 97.199 | 332 | 97.199 | |||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 1.810.262 | 6.191 | 1.810.262 | |||
| 2014-02-19 | 2014-02-16 | 4 | Williams Gregory C. | NONE | Stock Option (Right to Buy) | D | 3,42 | 3,4200 | 400.000 | 1.368 | 400.000 | |||
| 2014-01-06 | 2013-12-31 | 4 | Nordic Bioscience Clinical Development VII A/S | NONE | Series A-6 Convertible Preferred Stock | D | 496.111 | 5.025.540 | ||||||
| 2013-12-06 | 3 | Lyttle Cecil Richard | NONE | Common Stock | D | 66.666 | ||||||||
| 2013-11-18 | 2013-11-14 | 4 | Fromkin Andrew J. | NONE | Stock Option (Right to Buy) | D | 3,45 | 3,4500 | 2.427.133 | 8.374 | 2.427.133 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 407.034 | 2.500 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 162.813 | 10.000 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 227.939 | 1.400 | 227.939 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 91.175 | 5.600 | 91.175 | ||||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 227.939 | 1.400 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 91.175 | 5.600 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock Warrant | I | 6,14 | 6,1420 | 179.095 | 1.100 | 179.095 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | 61,4200 | 71.638 | 4.400 | 71.638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 179.095 | 179.095 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 71.638 | 4.400 | 71.638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 3.670 | 3.670 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 1.468 | 90 | 1.468 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 5.728 | 5.728 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 2.291 | 141 | 2.291 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 16.035 | 16.035 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 6.414 | 394 | 6.414 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 189.748 | 189.748 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 75.899 | 4.662 | 75.899 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6,14 | 12.758 | 12.758 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 5.103 | 313 | 5.103 | ||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6,14 | 81.408 | 81.408 | |||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Series B Convertible Preferred Stock | I | 61,4200 | 32.563 | 2.000 | 32.563 | ||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6,14 | 244.220 | 244.220 | |||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Series B Convertible Preferred Stock | D | 61,4200 | 97.688 | 6.000 | 97.688 | ||||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 62.700 | 244 | 451.700 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 37.600 | 146 | 389.000 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | 351.400 | 1.367 | 351.400 | |||
| 2012-06-22 | 2011-12-15 | 4 | WYZGA MICHAEL S | NONE | Stock Option (Right to Buy) | D | 3,89 | 3,8900 | -1.530.000 | -5.952 | 1.530.000 | |||
| 2012-06-19 | 2012-04-11 | 4 | Franken Michael | NONE | Stock Option (Right to Buy) | D | 4,21 | 4,2100 | 70.000 | 295 | 70.000 | |||
| 2012-02-02 | 2011-12-14 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81,4200 | 40.940 | 3.333 | 122.820 | ||||
| 2012-02-02 | 2011-11-18 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81,4200 | 40.940 | 3.333 | 81.880 | ||||
| 2011-05-24 | 3 | CAVANAUGH JAMES H | NONE | Common Stock | D | 83.113 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
